Arginase: a multifaceted enzyme important in health and disease
RW Caldwell, PC Rodriguez, HA Toque… - Physiological …, 2018 - journals.physiology.org
The arginase enzyme developed in early life forms and was maintained during evolution. As
the last step in the urea cycle, arginase cleaves l-arginine to form urea and l-ornithine. The …
the last step in the urea cycle, arginase cleaves l-arginine to form urea and l-ornithine. The …
[HTML][HTML] Metabolism and function of polyamines in cancer progression
IN Sari, T Setiawan, KS Kim, YT Wijaya, KW Cho… - Cancer Letters, 2021 - Elsevier
Polyamines are essential for the proliferation, differentiation, and development of
eukaryotes. They include spermine, spermidine, and the diamine precursor putrescine, and …
eukaryotes. They include spermine, spermidine, and the diamine precursor putrescine, and …
S‐adenosylmethionine: a metabolite critical to the regulation of autophagy
Y Ouyang, Q Wu, J Li, S Sun, S Sun - Cell proliferation, 2020 - Wiley Online Library
Autophagy is a mechanism that enables cells to maintain cellular homeostasis by removing
damaged materials and mobilizing energy reserves in conditions of starvation. Although …
damaged materials and mobilizing energy reserves in conditions of starvation. Although …
[HTML][HTML] Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas
Diffuse intrinsic pontine glioma (DIPG) is an incurable malignant childhood brain tumor, with
no active systemic therapies and a 5-year survival of less than 1%. Polyamines are small …
no active systemic therapies and a 5-year survival of less than 1%. Polyamines are small …
[HTML][HTML] Wnt/β-catenin signaling: the culprit in pancreatic carcinogenesis and therapeutic resistance
Pancreatic ductal adenocarcinoma (PDAC) is responsible for 7.3% of all cancer deaths.
Even though there is a steady increase in patient survival for most cancers over the …
Even though there is a steady increase in patient survival for most cancers over the …
[HTML][HTML] Alpha-difluoromethylornithine, an irreversible inhibitor of polyamine biosynthesis, as a therapeutic strategy against hyperproliferative and infectious diseases
N LoGiudice, L Le, I Abuan, Y Leizorek, SC Roberts - Medical Sciences, 2018 - mdpi.com
The fluorinated ornithine analog α-difluoromethylornithine (DFMO, eflornithine, ornidyl) is an
irreversible suicide inhibitor of ornithine decarboxylase (ODC), the first and rate-limiting …
irreversible suicide inhibitor of ornithine decarboxylase (ODC), the first and rate-limiting …
eIF5A-PEAK1 signaling regulates YAP1/TAZ protein expression and pancreatic cancer cell growth
In pancreatic ductal adenocarcinoma (PDAC), mutant KRAS stimulates the translation
initiation factor eIF5A and upregulates the focal adhesion kinase PEAK1, which transmits …
initiation factor eIF5A and upregulates the focal adhesion kinase PEAK1, which transmits …
[HTML][HTML] Differential expression of polyamine pathways in human pancreatic tumor progression and effects of polyamine blockade on tumor microenvironment
Simple Summary Pancreatic cancer has a five-year survival rate of less than 8% and is the
fourth leading cause of cancer death in the United States. Existing therapeutics have failed …
fourth leading cause of cancer death in the United States. Existing therapeutics have failed …
Multifunctionalized gold sub‐nanometer particles for sensitizing radiotherapy against glioblastoma
CY Dong, S Hong, DW Zheng, QX Huang, FS Liu… - Small, 2021 - Wiley Online Library
Glioblastoma is the most common lethal malignant intracranial tumor with a low 5‐year
survival rate. Currently, the maximal safe surgical resection, followed by high‐dose …
survival rate. Currently, the maximal safe surgical resection, followed by high‐dose …
[HTML][HTML] Arginine metabolism: a potential target in pancreatic cancer therapy
JS Yang, CC Wang, JD Qiu, B Ren… - Chinese medical …, 2021 - journals.lww.com
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …
extremely low survival rate of< 9% in the United States. As a new hallmark of cancer …